About UsProducts & ServicesNews & EventsInvestor RelationsCareers
All Press Releases
2007
2006
2005

Press Releases

Mellon HBV Establishes Hong Kong-Based Research Team
—Builds Research Effort in Asia —

NEW YORK, October 5, 2005 — Mellon HBV Alternative Strategies LLC, a subsidiary of Mellon Financial Corporation, today announced that it has established a specialist research team in Hong Kong to cover Asian markets. This team will support Mellon HBV's global multi-strategy discipline and identify further event-driven opportunities throughout Asia.

Andy Shpiz, Asian research director for Mellon HBV, will lead a team of three Mellon research analysts: Eddie Hui, fluent in Mandarin and Cantonese; Shen Lin, fluent in Mandarin; and Shizuka Lisa Saito, who is based in London and fluent in Japanese. Shpiz and Lin have been assigned to Mellon Global Investments (MGI) Asia Limited's Hong Kong office on a temporary basis, where they will join MGI Asia's Hui to conduct research on Asia opportunities for Mellon HBV's portfolio managers.

"Asia is the next frontier for us," said Mickey Harley, chief executive officer at Mellon HBV. "With HBV now having access to local research provided by its MGI Asia affiliate, we are well positioned to capitalize on the many event-driven opportunities in the region."

Mellon HBV Alternative Strategies LLC is an investment management company that seeks superior risk-adjusted investment performance primarily for institutional investors via an array of alternative investment disciplines. Headquartered in New York with a wholly owned investment management subsidiary located in London, Mellon HBV has combined assets under management in excess of $1.1 billion in distressed (hedged distressed, long-biased trading oriented distressed, and long only control oriented distressed) and event-driven (Global Event Driven, U.S. Event Driven and European Event Driven) investing. Mellon HBV Alternative Strategies is a U.S. Securities and Exchange Commission registered investment advisor, and its subsidiary, Mellon HBV Alternative Strategies U.K. Limited, is regulated by the Financial Services Authority in the United Kingdom.

Mellon Financial Corporation is a global financial services company. Headquartered in Pittsburgh, Mellon is one of the world's leading providers of financial services for institutions, corporations and high net worth individuals, providing institutional asset management, mutual funds, private wealth management, asset servicing, payment solutions and investor services, and treasury services. Mellon has approximately $4.2 trillion in assets under management, administration or custody, including $738 billion under management. Its asset management companies include The Dreyfus Corporation and U.K.-based Newton Investment Management Limited. More about Mellon is available at www.mellon.com.

# # #